Mylan offers generic Angiomax injection
HERTFORDSHIRE, England and PITTSBURGH — Mylan N.V. announced the U.S. launch of bivalirudin for injection, 250 mg single-dose vial, a generic version of Angiomax from The Medicines Company. The product is a direct thrombin inhibitor indicated for use as an anticoagulant in patients. Mylan is offering bivalirudin for injection, 250 mg single-dose vial, to its hospital
